LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
+1.55%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$2.12B
AUM Growth
-$311M
(-13%)
Cap. Flow
-$388M
Cap. Flow
% of AUM
-18.34%
Top 10 Holdings %
Top 10 Hldgs %
41.81%
Holding
950
New
303
Increased
72
Reduced
76
Closed
405
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$173M |
| 2 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
$150M |
| 3 |
RTX Corp
RTX
|
$141M |
| 4 |
IAC Inc
IAC
|
$67.5M |
| 5 |
AGN
Allergan plc
AGN
|
$60.2M |
Top Sells
| 1 |
AABA
Altaba Inc. Common Stock
AABA
|
$210M |
| 2 |
CELG
Celgene Corp
CELG
|
$204M |
| 3 |
Netflix
NFLX
|
$117M |
| 4 |
Amazon
AMZN
|
$100M |
| 5 |
Adobe
ADBE
|
$99.8M |
Sector Composition
| 1 | Technology | 17.2% |
| 2 | Industrials | 12.88% |
| 3 | Communication Services | 10.27% |
| 4 | Healthcare | 9.94% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VGR
301
DELISTED
Vector Group Ltd.
VGR
| $599K | ﹤0.01% |
+63,027
| New | +$599K |
|
|
EPAY
302
DELISTED
Bottomline Technologies Inc
EPAY
| $590K | ﹤0.01% |
+11,000
| New | +$590K |
|
|
BOLD
303
DELISTED
Audentes Therapeutics, Inc
BOLD
| $589K | ﹤0.01% |
9,844
-12,256
| -55% | -$733K |
|
304
Arbor Realty Trust
ABR
$2.34B
| $588K | ﹤0.01% |
+40,946
| New | +$588K |
|
305
Cardlytics
CDLX
$49.6M
| $585K | ﹤0.01% |
9,300
-30,700
| -77% | -$1.93M |
|
306
CSG Systems International
CSGS
$1.86B
| $585K | ﹤0.01% |
+11,300
| New | +$585K |
|
307
Smith Micro Software
SMSI
$15.5M
| $585K | ﹤0.01% |
+18,388
| New | +$585K |
|
308
GATX Corp
GATX
$5.97B
| $570K | ﹤0.01% |
+6,883
| New | +$570K |
|
309
Lennar Class B
LEN.B
$35.3B
| $566K | ﹤0.01% |
13,312
+8,350
| +168% | +$355K |
|
310
Gray Television
GTN
$625M
| $562K | ﹤0.01% |
+26,200
| New | +$562K |
|
311
John Wiley & Sons Class A
WLY
$2.13B
| $562K | ﹤0.01% |
+11,575
| New | +$562K |
|
312
Fulcrum Therapeutics
FULC
$414M
| $558K | ﹤0.01% |
33,552
-61,200
| -65% | -$1.02M |
|
313
Veeva Systems
VEEV
$44.7B
| $557K | ﹤0.01% |
3,958
-6,554
| -62% | -$922K |
|
314
Ford
F
$46.7B
| $543K | ﹤0.01% |
58,478
+41,600
| +246% | +$386K |
|
|
PLYM
315
Plymouth Industrial REIT
PLYM
$998M
| $541K | ﹤0.01% |
29,400
+14,400
| +96% | +$265K |
|
316
Core Laboratories
CLB
$592M
| $536K | ﹤0.01% |
+14,241
| New | +$536K |
|
317
Novanta
NOVT
$4.18B
| $535K | ﹤0.01% |
+6,053
| New | +$535K |
|
318
Cabot Corp
CBT
$4.31B
| $527K | ﹤0.01% |
+11,100
| New | +$527K |
|
319
Evertec
EVTC
$2.21B
| $511K | ﹤0.01% |
+15,000
| New | +$511K |
|
320
First Bancorp
FBP
$3.54B
| $502K | ﹤0.01% |
+47,400
| New | +$502K |
|
321
iShares China Large-Cap ETF
FXI
$6.65B
| $494K | ﹤0.01% |
+11,319
| New | +$494K |
|
|
MANT
322
DELISTED
Mantech International Corp
MANT
| $487K | ﹤0.01% |
+6,100
| New | +$487K |
|
323
Coca-Cola Consolidated
COKE
$10.5B
| $483K | ﹤0.01% |
17,000
+3,590
| +27% | +$102K |
|
|
ELME
324
Elme Communities
ELME
$1.52B
| $479K | ﹤0.01% |
+16,402
| New | +$479K |
|
325
SPS Commerce
SPSC
$4.19B
| $477K | ﹤0.01% |
+8,600
| New | +$477K |
|